We are a go-to source for trusted public health expertise.
Arrests and incarceration won’t stop urban gun violence. Instead, a growing number of researchers say community violence prevention is the most promising solution.
Ending America’s Gun Violence Epidemic
From personal stories of survival to gun policies already making a difference—the latest issue of Hopkins Bloomberg Public Health magazine brings a public health lens to ending gun violence in the U.S.
Bloomberg American Health Summit 2021
Join us November 10 from 9:30 a.m. to 11 a.m. and 1 p.m. to 2:30 p.m. as speakers explore the most pressing topics in public health from the past year, including how to advance equity in underserved communities, lessons learned from the COVID-19 pandemic, and how best to prepare for the next public health crisis. Initiative fellows and faculty will highlight how their work is pushing U.S. public health forward.
Bridging Faith and Science to Combat the Overdose Crisis Series
On September 20, President Bill Clinton, Sister Simone Campbell, Dr. Nora Volkow, Dr. Leana Wen, and other leaders, discussed how the faith and public health communities can take action on the overdose crisis.
The second convening in this series, hosted by the Clinton Foundation, Johns Hopkins Bloomberg School of Public Health, and The Centre for Responsible Leadership, was held at 12:30 p.m., EDT, on Monday, September 20, with a focus on how local, state, and national government policy, informed by critical research, is necessary to address substance use disorders and reverse a dangerous trend of increasing overdose deaths.
How Do mRNA Vaccines Work? Here's What You Should Know
Messenger RNA—or mRNA—vaccines have been in development for decades, and are now approved for use against COVID-19.
Understanding the COVID-19 Variants
With new variants of SARS-CoV-2 emerging across the globe, what do you need to know?
We got some answers from Andy Pekosz, PhD, vice chair and professor in our department of molecular microbiology and immunology.
In the News
This year, doctors are highlighting the importance of vaccination for all eligible people. Being fully immunized against the coronavirus protects against contracting the virus, and significantly lowers the risk of severe illness or death.
If there are no bumps along the way, Pfizer/BioNTech could get emergency use authorization for the younger group of kids in the first two weeks of November.
The White House laid out plans Wednesday for children between the ages of 5 and 11 to soon receive the COVID-19 vaccine. If approved, shots could begin as soon as November.